Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

The role of adipokines in skeletal muscle inflammation and insulin sensitivity

(2018) Thomas Nicholson et al.   Journal of Inflammation-London

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

(2016) Xinfang Xie et al.   LANCET

Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement

(2015) Albert L. Siu   ANNALS OF INTERNAL MEDICINE

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

(2015) Suetonia C Palmer et al.   LANCET

Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension

(2015) Rui Xu et al.   MEDICINE

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Treating hypertension in type 2 diabetes

(2014) Yoni Grossman et al.   EXPERT OPINION ON PHARMACOTHERAPY

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

(2013) Giuseppe Mancia et al.   BLOOD PRESSURE

Comparison of the Efficacies of Irbesartan and Olmesartan after Successful Coronary Stent Implantation

(2013) Joji Morii et al.   INTERNAL MEDICINE

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Management of Home Blood Pressure by Amlodipine Combined With Angiotensin II Receptor Blocker in Type 2 Diabetes

(2012) Katsumi Miyauchi et al.   CIRCULATION JOURNAL

An Additional LDL-Lowering Effect of Amlodipine; Not Only an Antihypertensive?

(2012) Zekeriya Arslan et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Cardiovascular Outcomes in Framingham Participants With Diabetes

(2011) Guanmin Chen et al.   HYPERTENSION

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Masked Hypertension and the `Mask Effect' in Patients With Well-Controlled Office Blood Pressure

(2010) Sung-Ji Park et al.   CIRCULATION JOURNAL

Home-Measured Blood Pressure Is a Stronger Predictor of Cardiovascular Risk Than Office Blood Pressure

(2010) Teemu J. Niiranen et al.   HYPERTENSION

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation

(2009) Makoto Sugihara et al.   HYPERTENSION RESEARCH

Clinical estimation of fetal weight and the Hawthorne effect

(2008) Nathan S. Fox et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

(2008) Jan Östergren et al.   JOURNAL OF HYPERTENSION